Welcome to the Senedd's new website. If you have any difficulty using this site please get in touch.
Use of antipsychotic medication in care homes
The Health, Social Care and Sport Committee is undertaking a short inquiry on the use of antipsychotic medication in care homes. This was supported by stakeholders responding to the consultation on the Committee’s priorities.
Antipsychotics are a group of medications usually used in the treatment of mental health conditions such as schizophrenia. They are often inappropriately prescribed to control the behavioural and psychological symptoms of dementia. Their use in dementia patients is associated with a significant increased risk of harm. It’s been suggested that around two thirds of prescriptions of antipsychotics for people with dementia are inappropriate.
Reducing the number of people with a dementia diagnosis inappropriately receiving antipsychotic medication, particularly in care homes, is also identified as a key action in the Welsh Government’s draft dementia strategy.
Terms of reference:
The Committee will look at the use of antipsychotic medication in care home settings, and the ways in which its inappropriate use could be reduced, including the consideration of:
The Committee was inviting views on this issue. The deadline for responses was 21 April 2017.
Business type: Committee Inquiry
Reason considered: Senedd Business;
Status: For consideration
First published: 03/03/2017
- Report - Use of antipsychotic medication in care homes
- Welsh Government response
- Welsh Government response - further information from the Cabinet Secretary for Health and Social Services PDF 278 KB
- Use of antipsychotic medication in care homes (completed)